GeoVax Labs, Inc. is a biotechnology company, established to develop, manufacture, license and commercialize human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents. GeoVax's AIDS vaccine technology is the subject of 20 issued or filed patent applications. GeoVax AIDS vaccines are designed for use in uninfected people to prevent Acquired Immunodeficiency Disease (AIDS), caused by the virus known as HIV-1, should the person ever become infected. GeoVax AIDS vaccines also may be effective as therapeutics (treatment of people already infected with AIDS virus). Studies evaluating these vaccines in HIV/AIDS infected individuals are in the planning stage.
Company web site
geovax.com
Other forums
ragingbull.quote.com
siliconinvestor.com
HIV Vaccine Trials Network
hvtn.org
Google news search GeoVax
news.google.com
Google news search Emory and HIV
news.google.com
Partners:
VIVALIS for Use of its Revolutionary EBx® Technology to Manufacture
its MVA HIV/AIDS Vaccine
finance.yahoo.com
Emory University in Atlanta, Georgia (4/28/08) held 233,905,253 shares 32.0% |
